Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$63,167.00

Engineering low-cost nanotechnology based molecular diagnostics using paper

EF 2012-13

Résumé
Emerging infectious diseases continue to pose threats to hospitalized patients, individuals made vulnerable by immune compromise, and residents of long-term care facilities, as well as otherwise healthy community residents. The dynamic nature of microbial populations necessitates a nimble, dynamic, and creative approach to disease control, and requires continuous evolution of public health policy and practice. Here our objective is to create a simple, low cost device capable of detecting multiple microbial targets in a rapid manner. The successful creation of such a device would enable identification, assist in timely proper treatment, and could prevent their spread. Because of the short-timeframe of the project, we selected to focus on highly prevalent genital tract and sexually transmitted infections (STIs) and leverage our collaboration with the Ontario Public Health Laboratory, a high volume clinical testing facility with established experience in assay development, evaluation and clinical interpretation that also houses an extensive repository of archived clinical specimens and isolates. This project will provide the proof-of-concept for the feasibility of the technology and once established we should be able to adapt our methodologies to other infectious disease panels (e.g., blood-borne infection, respiratory, food-borne and gastro-enteric) into our device.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
398432-2011
Name nom
Chan, Warren
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
63167
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
2
Nb partie
3
Application title
Engineering low-cost nanotechnology based molecular diagnostics using paper
Keyword
NSERC
Application summary
Emerging infectious diseases continue to pose threats to hospitalized patients, individuals made vulnerable by immune compromise, and residents of long-term care facilities, as well as otherwise healthy community residents. The dynamic nature of microbial populations necessitates a nimble, dynamic, and creative approach to disease control, and requires continuous evolution of public health policy and practice. Here our objective is to create a simple, low cost device capable of detecting multiple microbial targets in a rapid manner. The successful creation of such a device would enable identification, assist in timely proper treatment, and could prevent their spread. Because of the short-timeframe of the project, we selected to focus on highly prevalent genital tract and sexually transmitted infections (STIs) and leverage our collaboration with the Ontario Public Health Laboratory, a high volume clinical testing facility with established experience in assay development, evaluation and clinical interpretation that also houses an extensive repository of archived clinical specimens and isolates. This project will provide the proof-of-concept for the feasibility of the technology and once established we should be able to adapt our methodologies to other infectious disease panels (e.g., blood-borne infection, respiratory, food-borne and gastro-enteric) into our device.